WAUKESHA, Wis. (PRWEB) May 30, 2020
Coppe Healthcare Solutions (Coppe Laboratories), a CLIA Certified Laboratory based in Waukesha, Wisconsin, has completed a Joint Venture agreement with Open CoVIDx, a CLIA certified Laboratory based in San Francisco Bay area of California.
The Joint Venture will be called Coppe-Open CoVIDx Laboratories, and will combine the laboratory capacities of the two for a total of 1.5 Million COVID-19 diagnostic tests per month, by end of June 2020. The increased capacity will put the venture among the top 5 COVID-19 testing Laboratories in the United States.
The Coppe-Open CoVIDx Laboratories will provide employers in the USA and Kenya with COVID-19 diagnostic testing for employees, environmental testing of work places, and antibody testing within the FDA approved guidelines.
About Coppe – http://www.coppelabs.com
Coppe is a Wisconsin-based CLIA-certified laboratory focused on infectious diseases testing. The CEO of Coppe Laboratories is Dr. Konstance Knox, the virologist who previously co-founded what is now Viracor-Eurofins in 2000. Dr. Knox has expanded Coppe's testing footprint to serve 1,000 Doctor's Offices in the United States, and internationally with a Coppe run Laboratory at the new 5,000 bed Hamptons Hospital, under development at Mwale Medical and Technology City (MMTC) in Kenya.
About Open CoVIDx – http://www.opencovidx.org
Open CoVIDx is a San Francisco Bay Area CLIA-certified lab focused on large scale SARS-CoV-2 (COVID-19) testing through laboratory automation and innovative use of biotechnologies. Open CoVIDx was formed from partnerships with OpenTrons (http://www.opentrons.com) and multiple laboratory test vendors serving national and international clients.
For media inquiries please email email@example.com